2-48620875-G-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_006872.5(GTF2A1L):​c.46G>C​(p.Glu16Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000032 in 1,594,108 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000032 ( 3 hom. )

Consequence

GTF2A1L
NM_006872.5 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.73
Variant links:
Genes affected
GTF2A1L (HGNC:30727): (general transcription factor IIA subunit 1 like) The assembly and stability of the RNA polymerase II transcription pre-initiation complex on a eukaryotic core promoter involve the effects of transcription factor IIA (TFIIA) on the interaction between TATA-binding protein (TBP) and DNA. This gene encodes a germ cell-specific counterpart of the large (alpha/beta) subunit of general transcription factor TFIIA that is able to stabilize the binding of TBP to DNA and may be uniquely important to testis biology. Alternative splicing for this locus has been observed and two variants, encoding distinct isoforms, have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (SALF), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Mar 2014]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3086327).
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GTF2A1LNM_006872.5 linkc.46G>C p.Glu16Gln missense_variant Exon 2 of 9 ENST00000403751.8 NP_006863.2 Q9UNN4-1A0A140VKA3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GTF2A1LENST00000403751.8 linkc.46G>C p.Glu16Gln missense_variant Exon 2 of 9 1 NM_006872.5 ENSP00000384597.3 Q9UNN4-1
STON1-GTF2A1LENST00000394754.5 linkc.2158G>C p.Glu720Gln missense_variant Exon 4 of 11 1 ENSP00000378236.1 Q53S48

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
152036
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000418
AC:
10
AN:
238956
AF XY:
0.0000693
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000575
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000520
GnomAD4 exome
AF:
0.0000319
AC:
46
AN:
1441954
Hom.:
3
Cov.:
31
AF XY:
0.0000391
AC XY:
28
AN XY:
716836
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32762
American (AMR)
AF:
0.00
AC:
0
AN:
41954
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25724
East Asian (EAS)
AF:
0.000181
AC:
7
AN:
38682
South Asian (SAS)
AF:
0.000316
AC:
26
AN:
82202
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52702
Middle Eastern (MID)
AF:
0.000702
AC:
4
AN:
5700
European-Non Finnish (NFE)
AF:
0.00000272
AC:
3
AN:
1102830
Other (OTH)
AF:
0.000101
AC:
6
AN:
59398
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152154
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41530
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10552
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68004
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.0000264
ExAC
AF:
0.0000412
AC:
5
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 12, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.46G>C (p.E16Q) alteration is located in exon 2 (coding exon 2) of the GTF2A1L gene. This alteration results from a G to C substitution at nucleotide position 46, causing the glutamic acid (E) at amino acid position 16 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.26
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.17
.;.;.;.;.;T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
.;D;D;D;D;D
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.31
T;T;T;T;T;T
MetaSVM
Benign
-0.30
T
MutationAssessor
Uncertain
2.9
.;.;.;.;.;M
PhyloP100
7.7
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-1.7
N;N;N;N;N;N
REVEL
Benign
0.22
Sift
Benign
0.058
T;T;T;T;D;D
Sift4G
Benign
0.070
T;T;T;T;D;D
Polyphen
1.0
D;.;D;.;.;D
Vest4
0.71
MutPred
0.66
Gain of helix (P = 0.0199);Gain of helix (P = 0.0199);Gain of helix (P = 0.0199);Gain of helix (P = 0.0199);.;.;
MVP
0.39
MPC
0.013, 0.033
ClinPred
0.33
T
GERP RS
4.7
Varity_R
0.47
gMVP
0.33
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs555948703; hg19: chr2-48848014; API